Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4554849
Max Phase: Preclinical
Molecular Formula: C25H25F3N4O3
Molecular Weight: 486.49
Molecule Type: Unknown
Associated Items:
ID: ALA4554849
Max Phase: Preclinical
Molecular Formula: C25H25F3N4O3
Molecular Weight: 486.49
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)[C@H]1[C@@H]2C[C@@H](OC3CCN(c4ccc(-c5nc6cc(C(F)(F)F)ccc6[nH]5)cn4)CC3)C[C@@H]21
Standard InChI: InChI=1S/C25H25F3N4O3/c26-25(27,28)14-2-3-19-20(9-14)31-23(30-19)13-1-4-21(29-12-13)32-7-5-15(6-8-32)35-16-10-17-18(11-16)22(17)24(33)34/h1-4,9,12,15-18,22H,5-8,10-11H2,(H,30,31)(H,33,34)/t16-,17-,18+,22+
Standard InChI Key: PVTQXWOCZXCWFB-VPPVLBTASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 486.49 | Molecular Weight (Monoisotopic): 486.1879 | AlogP: 4.74 | #Rotatable Bonds: 5 |
Polar Surface Area: 91.34 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.39 | CX Basic pKa: 6.34 | CX LogP: 2.24 | CX LogD: 1.30 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.54 | Np Likeness Score: -1.00 |
1. He S, Lai Z, Hong Q, Shang J, Reibarkh M, Kuethe JT, Liu J, Guiadeen D, Krikorian AD, Cernak TA, Dykstra KD, Sperbeck DM, Wu Z, Yu Y, Yang GX, Jian T, Verras A, Sonatore LM, Wiltsie J, Chung CC, Murphy BA, Gorski JN, Liu J, Xiao J, Wolff M, Tong SX, Madeira M, Karanam BV, Shen DM, Balkovec JM, Pinto S, Nargund RP, DeVita RJ.. (2019) Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety., 29 (10): [PMID:30926247] [10.1016/j.bmcl.2019.03.025] |
Source(1):